生活方式干预对老年冠心病防控的研究进展

曹丰, 吴雪萍. 生活方式干预对老年冠心病防控的研究进展[J]. 临床心血管病杂志, 2024, 40(10): 785-789. doi: 10.13201/j.issn.1001-1439.2024.10.002
引用本文: 曹丰, 吴雪萍. 生活方式干预对老年冠心病防控的研究进展[J]. 临床心血管病杂志, 2024, 40(10): 785-789. doi: 10.13201/j.issn.1001-1439.2024.10.002
CAO Feng, WU Xueping. Lifestyle intervention for the prevention of coronary heart disease in the elderly[J]. J Clin Cardiol, 2024, 40(10): 785-789. doi: 10.13201/j.issn.1001-1439.2024.10.002
Citation: CAO Feng, WU Xueping. Lifestyle intervention for the prevention of coronary heart disease in the elderly[J]. J Clin Cardiol, 2024, 40(10): 785-789. doi: 10.13201/j.issn.1001-1439.2024.10.002

生活方式干预对老年冠心病防控的研究进展

  • 基金项目:
    国家科技部重点研发计划(No: 2022YFC3602404); 北京市重点项目丰台重点研究专题(No: L241026)
详细信息

Lifestyle intervention for the prevention of coronary heart disease in the elderly

More Information
  • 我国老年冠心病患病率及病死率逐年上升,经济及医疗负担重。冠心病有多个危险因素,健康生活方式改变可降低冠心病发病率。以运动为主的生活方式改变能改善老年冠心病多种危险因素并预防冠心病。
  • 加载中
  • 图 1  运动对心血管的益处

    Figure 1.  Cardiovascular benefits of exercise

    表 1  老年人冠心病一级预防的运动方案

    Table 1.  Exercise program for primary prevention of coronary heart disease in the elderly people

    老年人群 运动类型 内容 频率及时间
    健康老年人 有氧运动 步行、水中有氧运动、跳舞、平地骑自行车 每周至少150 min
    平衡及柔韧性运动 拉伸、平衡等训练 每周至少2 d
    抗阻运动 提重物、瑜伽和普拉提运动等 每周至少2 d
    有运动习惯老年人或老年运动员 可继续以往运动类型及强度,每年运动心肺实验评估调整运动量
    体弱老年人 先评估以确定运动类型及强度,每4周增加运动量及持续时间
    下载: 导出CSV
  • [1]

    Li Y, Cao GY, Jing WZ, et al. Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990-2019: findings from 2019 global burden of disease study[J]. Eur J Prev Cardiol, 2023, 30(3): 276-286. doi: 10.1093/eurjpc/zwac285

    [2]

    Qu C, Liao S, Zhang J, et al. Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019[J]. Eur Heart J Qual Care Clin Outcomes, 2024, 10(2): 143-153. doi: 10.1093/ehjqcco/qcad033

    [3]

    曹丰, 王亚斌, 薛万国, 等. 中国老年疾病临床多中心报告[J]. 中华老年多器官疾病杂志, 2018, 17(11): 801-808. doi: 10.11915/j.issn.1671-5403.2018.11.185

    [4]

    国家统计局. 中华人民共和国2023年国民经济和社会发展统计公报[N]. 人民日报, 2024-03-01(010).

    [5]

    马丽媛, 王增武, 樊静, 等. 《中国心血管健康与疾病报告2022》要点解读[J]. 中国全科医学, 2023, 26(32): 3975-3994. doi: 10.12114/j.issn.1007-9572.2023.0408

    [6]

    Bullard T, Ji M, An R, et al. A systematic review and meta-analysis of adherence to physical activity interventions among three chronic conditions: cancer, cardiovascular disease, and diabetes[J]. BMC Public Health, 2019, 19(1): 636. doi: 10.1186/s12889-019-6877-z

    [7]

    Hu X, Knibbs LD, Zhou Y, et al. The role of lifestyle in the association between long-term ambient air pollution exposure and cardiovascular disease: a national cohort study in China[J]. BMC Med, 2024, 22(1): 93. doi: 10.1186/s12916-024-03316-z

    [8]

    Kim HC. Epidemiology of cardiovascular disease and its risk factors in Korea[J]. Glob Health Med, 2021, 3(3): 134-141. doi: 10.35772/ghm.2021.01008

    [9]

    Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation, 2019, 140(11): e596-e646.

    [10]

    Wang XX, Nyabuto C. Chronic disease intervention in patients with cardiovascular disorders: a systematic review[J]. Eur Rev Med Pharmacol Sci, 2024, 28(4): 1490-1503.

    [11]

    Ma H, Wang X, Xue Q, et al. Cardiovascular Health and Life Expectancy Among Adults in the United States[J]. Circulation, 2023, 147(15): 1137-1146. doi: 10.1161/CIRCULATIONAHA.122.062457

    [12]

    Prugger C, Perier MC, Sabia S, et al. Association between changes in cardiovascular health and the risk of multimorbidity: community-based cohort studies in the UK and Finland[J]. Lancet Reg Health Eur, 2024, 42: 100922. doi: 10.1016/j.lanepe.2024.100922

    [13]

    Yang PS, Jang E, Yu HT, et al. Changes in cardiovascular risk factors and cardiovascular events in the elderly population[J]. J Am Heart Assoc, 2021, 10(11): e019482. doi: 10.1161/JAHA.120.019482

    [14]

    Xia X, Chen S, Tian X, et al. Cardiovascular health and life expectancy with and without cardiovascular disease in the middle-aged and elderly Chinese population[J]. BMC Public Health, 2023, 23(1): 2528. doi: 10.1186/s12889-023-17456-z

    [15]

    Chen B. Patiromer for hyperkalaemia in heart failure[J]. Drug Ther Bull, 2022, 60(12): 182. doi: 10.1136/dtb.2022.000063

    [16]

    Lloyd-Jones DM, Allen NB, Anderson C, et al. Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association[J]. Circulation, 2022, 146(5): e18-e43.

    [17]

    Lehtisalo J, Rusanen M, Solomon A, et al. Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial[J]. Eur Heart J, 2022, 43(21): 2054-2061. doi: 10.1093/eurheartj/ehab922

    [18]

    van den Berg MJ, van der Graaf Y, Deckers JW, et al. Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial disease[J]. Am Heart J, 2019, 213: 112-122. doi: 10.1016/j.ahj.2019.03.019

    [19]

    Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association[J]. Circulation, 2019, 139(10): e56-e528.

    [20]

    Alibhai FJ, Li RK. Rejuvenation of the aging heart: molecular determinants and applications[J]. Can J Cardiol, 2024, 40(8): 1394-1411. doi: 10.1016/j.cjca.2024.03.004

    [21]

    Chen C, Zheng Y, Wu Y, et al. The association between time-restricted eating and arterial stiffness status in community-dwelling elderly Chinese individuals[J]. Nutr Metab Cardiovasc Dis, 2024, 34(5): 1217-1225. doi: 10.1016/j.numecd.2024.01.009

    [22]

    Ozcan M, Abdellatif M, Javaheri A, et al. Risks and benefits of intermittent fasting for the aging cardiovascular system[J]. Can J Cardiol, 2024, 40(8): 1445-1457. doi: 10.1016/j.cjca.2024.02.004

    [23]

    Dai Y, Sun Z, Zheng Y, et al. Recent advances in the gut microbiome and microbial metabolites alterations of coronary artery disease[J]. Sci Bull(Beijing), 2023, 68(6): 549-552.

    [24]

    Binu AJ, Kapoor N, Bhattacharya S, et al. Sarcopenic obesity as a risk factor for cardiovascular disease: an underrecognized clinical entity[J]. Heart Int, 2023, 17(2): 6-11. doi: 10.17925/HI.2023.17.2.4

    [25]

    Jiang M, Ren X, Han L, et al. Associations between sarcopenic obesity and risk of cardiovascular disease: A population-based cohort study among middle-aged and older adults using the CHARLS[J]. Clin Nutr, 2024, 43(3): 796-802. doi: 10.1016/j.clnu.2024.02.002

    [26]

    黄志华, 赵智慧, 赵青. 心血管疾病患者阻塞性睡眠呼吸暂停评估与管理专家共识(2024版)[J]. 中国循环杂志, 2024, 39(5): 417-432. doi: 10.3969/j.issn.1000-3614.2024.05.001

    [27]

    Lee DH, Rezende L, Joh HK, et al. Long-term leisure-time physical activity intensity and all-cause and cause-specific mortality: a prospective cohort of US Adults[J]. Circulation, 2022, 146(7): 523-534. doi: 10.1161/CIRCULATIONAHA.121.058162

    [28]

    Blodgett JM, Ahmadi MN, Atkin AJ, et al. Device-measured physical activity and cardiometabolic health: the Prospective Physical Activity, Sitting, and Sleep(ProPASS)consortium[J]. Eur Heart J, 2024, 45(6): 458-471. doi: 10.1093/eurheartj/ehad717

    [29]

    Rippe JM. Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease[J]. Am J Lifestyle Med, 2019, 13(2): 204-212. doi: 10.1177/1559827618812395

    [30]

    Valenzuela PL, Ruilope LM, Santos-Lozano A, et al. Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation[J]. Eur Heart J, 2023, 44(21): 1874-1889. doi: 10.1093/eurheartj/ehad170

    [31]

    Zureigat H, Osborne MT, Abohashem S, et al. Effect of stress-related neural pathways on the cardiovascular benefit of physical activity[J]. J Am Coll Cardiol, 2024, 83(16): 1543-1553. doi: 10.1016/j.jacc.2024.02.029

    [32]

    Valenzuela PL, Carrera-Bastos P, Gálvez BG, et al. Lifestyle interventions for the prevention and treatment of hypertension[J]. Nat Rev Cardiol, 2021, 18(4): 251-275. doi: 10.1038/s41569-020-00437-9

    [33]

    Mendes BF, Improta-Caria AC, Diniz E Magalhães CO, et al. Resistance training reduces blood pressure: putative molecular mechanisms[J]. Curr Hypertens Rev, 2024, 20(1): 52-56. doi: 10.2174/0115734021277791240102041632

    [34]

    Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease[J]. Eur Heart J, 2021, 42(1): 17-96. doi: 10.1093/eurheartj/ehaa605

    [35]

    Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour[J]. Br J Sports Med, 2020, 54(24): 1451-1462. doi: 10.1136/bjsports-2020-102955

    [36]

    López-Bueno R, Ahmadi M, Stamatakis E, et al. Prospective associations of different combinations of aerobic and muscle-strengthening activity with all-cause, cardiovascular, and cancer mortality[J]. JAMA Intern Med, 2023, 183(9): 982-990. doi: 10.1001/jamainternmed.2023.3093

    [37]

    Ahmadi MN, Clare PJ, Katzmarzyk PT, et al. Vigorous physical activity, incident heart disease, and cancer: how little is enough?[J]. Eur Heart J, 2022, 43(46): 4801-4814. doi: 10.1093/eurheartj/ehac572

    [38]

    Ahmadi MN, Hamer M, Gill J, et al. Brief bouts of device-measured intermittent lifestyle physical activity and its association with major adverse cardiovascular events and mortality in people who do not exercise: a prospective cohort study[J]. Lancet Public Health, 2023, 8(10): e800-e810. doi: 10.1016/S2468-2667(23)00183-4

    [39]

    Feng H, Yang L, Liang YY, et al. Associations of timing of physical activity with all-cause and cause-specific mortality in a prospective cohort study[J]. Nat Commun, 2023, 14(1): 930. doi: 10.1038/s41467-023-36546-5

    [40]

    Gonzalez-Jaramillo N, Wilhelm M, Arango-Rivas AM, et al. Systematic review of physical activity trajectories and mortality in patients with coronary artery disease[J]. J Am Coll Cardiol, 2022, 79(17): 1690-1700. doi: 10.1016/j.jacc.2022.02.036

    [41]

    Li T, Jiang H, Ding J. The role of exercise-based cardiac rehabilitation after percutaneous coronary intervention in patients with coronary artery disease: a meta-analysis of randomised controlled trials[J]. Acta Cardiol, 2024, 79(2): 127-135. doi: 10.1080/00015385.2023.2266650

    [42]

    Li Y, Zhang H, Wang Y. Tai Chi Ameliorates coronary heart disease by affecting serum levels of miR-24 and miR-155[J]. Front Physiol, 2019, 10: 587. doi: 10.3389/fphys.2019.00587

    [43]

    Li Z, Guo K, Yang Y, et al. Exercise-based cardiac rehabilitation for patients with coronary heart disease: a systematic review and evidence mapping study[J]. Eur J Phys Rehabil Med, 2024, 60(2): 361-372.

    [44]

    Dibben G, Faulkner J, Oldridge N, et al. Exercise-based cardiac rehabilitation for coronary heart disease[J]. Cochrane Database Syst Rev, 2021, 11(11): CD001800.

  • 加载中

(1)

(1)

计量
  • 文章访问数:  1228
  • PDF下载数:  680
  • 施引文献:  0
出版历程
收稿日期:  2024-08-07
刊出日期:  2024-10-13

目录